Discover 1,922 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,922
Active & Responsive
Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer
for
Non Small Cell Lung Cancer (NSCLC)
Location: Dallas TX, Philadelphia PA
Sponsor: Integro Theranostics
Sex: All
Age: 18+
Code: NCT07276789
Phase2, Recruiting
Active & Responsive
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
for
Phenylketonuria
Location: Dallas TX, Houston TX, Nashville TN, Chicago IL,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 18+
Code: NCT06971731
Phase3, Recruiting
Active & Responsive
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Dallas TX, Birmingham AL, Indianapolis IN,
Sponsor: Girish Dhall, MD
Sex: All
Age: 16+
Code: NCT06502171
Phase1, Recruiting
Active & Responsive
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
Location: Dallas TX, Aurora CO, Atlanta GA, Minneapolis MN,
Sponsor: Spur Therapeutics
Sex: All
Age: 18+
Code: NCT07223944
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: Dallas TX, Oklahoma City OK, Jackson MS, Nashville TN,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07100990
Phase3, Recruiting
Active & Responsive
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Dallas TX, Houston TX, San Antonio TX, Kansas City KS,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT05303519
Phase3, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Location: Dallas TX, Houston TX, Little Rock AR, Phoenix AZ,
Sponsor: Carl Allen
Sex: All
Age: 0+
Code: NCT04079179
Phase2, Recruiting
Active & Responsive
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment
for
Alagille Syndrome
Location: Dallas TX, Memphis TN, Kansas City MO, St Louis MO,
Sponsor: Ipsen
Sex: All
Age: 0+
Code: NCT06850038
Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)
for
Niemann-Pick Type C Disease
Location: Dallas TX, Rochester MN, Minneapolis MN, Fairfax VA,
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer